PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding PolyPid Ltd. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 12 | 14 | +2 |
| Shares | 1.92M | 2.47M | +548.5K (+28.5%) |
| Value | $6.64M | $7.50M | +$863.0K (+13.0%) |
New holders (3)
Institutions that held PolyPid Ltd. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 128,483 | $390.6K | 0.01% |
| BNP Paribas Arbitrage, SA | 834 | $2.63K | 0.00% |
| SBI Securities Co., Ltd. | 1 | $3 | 0.00% |
Sold out (1)
Institutions that held PolyPid Ltd. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Golden State Equity Partners | 90 | $309 |